Acumen Hypotension Prediction Index (HPI) Feature Software vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Rhythm360

by RhythmScience

AI Verdict

Tool A is specifically designed for real-time prediction and proactive management of acute hypotensive events within critical care settings, integrating with a proprietary monitoring platform. In contrast, Tool B offers a broader, vendor-neutral platform for aggregating and analyzing cardiac monitoring data from various devices, focusing on workflow efficiency, alert reduction, and comprehensive management of conditions like hypertension, heart failure, and arrhythmias. While both utilize AI in cardiology, they address distinct clinical needs and operational challenges.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen HPI if your primary goal is real-time, proactive prevention and management of acute hypotensive events in high-acuity settings like the OR or ICU. This tool is ideal for clinicians needing immediate, predictive insights into hemodynamic instability to intervene before a critical event occurs, improving intraoperative and critical care patient outcomes.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Rhythm360 if…

Choose Rhythm360 if your cardiology practice requires a comprehensive, vendor-neutral platform to aggregate and analyze cardiac monitoring data from diverse devices for long-term patient management. This solution is best suited for optimizing workflows, reducing alert fatigue, and gaining actionable insights across hypertension, heart failure, and rhythm management, particularly for remote patient monitoring and automated billing.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Rhythm360
Pricing	Unknown	Flexible pricing model that scales with clinic size and platform usage.
Deployment	Unknown	Cloud-based SaaS platform
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 (Tool B) offers a cloud-based SaaS platform with a mobile application, vendor-neutral data aggregation, and extensive bi-directional EHR integration, suggesting broader accessibility and better workflow integration. Its AI-driven alert triage also aims to reduce alert fatigue and streamline clinician workflows. Acumen HPI (Tool A) is integrated into a specific proprietary hardware platform, which may limit its flexibility and integration options for diverse healthcare environments.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool A) provides a direct, measurable clinical benefit by predicting hypotension up to 15 minutes before an event and has 'demonstrated reduction in incidence, duration, and severity of intraoperative hypotension'. This addresses a critical, acute patient safety issue with a clear, quantifiable impact. While Rhythm360 (Tool B) offers significant value in chronic cardiac care management and alert reduction, Tool A's specific, life-saving predictive capability for an acute event gives it a slight edge in direct clinical impact based on the provided information.

Pricing & Value

Rhythm360

Rhythm360 (Tool B) offers more transparency with a 'flexible pricing model that scales with clinic size and platform usage' and explicitly mentions features like automated CPT code documentation and billing, which directly add financial value and operational efficiency. Acumen HPI (Tool A) provides no public pricing information, requiring direct vendor contact, which makes assessing its value proposition more challenging.

Enterprise Readiness

Rhythm360

Rhythm360 (Tool B) demonstrates superior enterprise readiness with its cloud-based SaaS deployment, vendor-neutral data aggregation across major OEMs, and extensive bi-directional EHR integration with leading systems like Epic and Cerner. Both tools are HIPAA compliant and have BAAs, but Tool B's broader integration capabilities make it more adaptable to complex enterprise IT environments. Acumen HPI (Tool A) is integrated into a specific proprietary platform, which may limit its enterprise-wide deployment flexibility.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool A) is described as a 'first-of-its-kind technology' that uses machine learning to predict a critical event like hypotension up to 15 minutes in advance, directly impacting acute patient safety. While Rhythm360 (Tool B) showcases significant innovation in data aggregation, AI-driven alert triage, and advanced data normalization, Tool A's novel predictive capability for a specific, life-threatening physiological event stands out as a unique innovation in real-time patient monitoring.

Support & Docs

Rhythm360

Rhythm360 (Tool B) explicitly offers 'Optional 24/7/365 oversight by certified cardiac technicians (CCTs),' indicating a robust and comprehensive support structure. Acumen HPI (Tool A) provides no information regarding its support offerings or documentation in the provided facts, making it impossible to assess this dimension for Tool A.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Rhythm360
Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Rhythm360
Company	Edwards Lifesciences	RhythmScience
Description	A predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes.	An AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Primary Clinical Focus	Hypotension Prediction and Hemodynamic Management	Hypertension, Heart Failure, and Rhythm Management
Key Features (Examples)	Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen, Relationship View screen providing insights into preload, afterload, and contractility	Vendor-neutral data aggregation, AI-driven alert triage, Bi-directional EHR integration, Automated CPT code documentation and billing
Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Rhythm360.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and patient populations for each tool?

Tool A, Acumen Hypotension Prediction Index (HPI) software, is designed for proactive hemodynamic management, detecting and alerting clinicians to the likelihood of a hypotensive event up to 15 minutes before it occurs, primarily in surgical and non-surgical patients receiving advanced hemodynamic monitoring. Tool B, Rhythm360, is an AI-powered platform that unifies cardiac monitoring data from various devices to provide insights for hypertension, heart failure, and rhythm management, aiming to reduce alert fatigue in cardiology patients.

How do these tools integrate into existing clinical workflows and infrastructure?

Acumen HPI software is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform and is compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. Rhythm360 is a cloud-based SaaS platform that offers vendor-neutral data aggregation from all major cardiac device OEMs (e.g., Medtronic, Boston Scientific, Abbott, Biotronik) and bi-directional EHR integration with systems like Epic, Cerner, Athenahealth, and eClinicalWorks.

What specific types of data do these tools utilize and how do they process it?

Acumen HPI software uses machine learning algorithms to analyze blood pressure waveforms and generate a Hypotension Prediction Index (HPI) parameter (0-100 score), along with providing insights into preload, afterload, and contractility. Rhythm360 utilizes AI Data Normalization, processing data from various cardiac devices via API, HL7, XML, and PDF parsing through computer vision, to unify cardiac monitoring data.

What are the key differences in their regulatory clearances or compliance?

Acumen HPI software has FDA clearance as an adjunctive predictive cardiovascular indicator, and is HIPAA compliant with a BAA available. Rhythm360 is HIPAA compliant and offers a BAA, but FDA clearance is not mentioned in the provided information.

What are the reported benefits or outcomes associated with using each tool?

Acumen HPI software has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. Rhythm360 reports benefits such as 80% faster response times for critical alerts, reduction in alert fatigue, and automated CPT code documentation and billing, which can lead to significant revenue increases.

Do these tools offer any support or oversight services?

Acumen HPI software is supported by Edwards Lifesciences, which provides customer service and technical support. Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) and remote technical and patient engagement services.